Classes
- Malignancies of B and T lymphocytes +6CCOC8959 | Third Faculty of Medicine
- Student Research ActivityC3SVA0061 | Third Faculty of Medicine
- Summer Practice in Compulsory FieldC5VL017 | Third Faculty of Medicine
- ?CCOC5938 | Third Faculty of Medicine
- . +1CCOC5938L | Third Faculty of Medicine
- Autoimune endocrinopathiesCCOC6922 | Third Faculty of Medicine
- Clinical Manifestation of Immune DisordersCCOC71S | Third Faculty of Medicine
- Basic skills in Emergency medical service +1CCOCA0004 | Third Faculty of Medicine
- Basic skill of physician in emergency dutiesCCOCA0023 | Third Faculty of Medicine
- Principles of Evidence-based Medicine and Basic research TrainingCCVOL25 | Third Faculty of Medicine
Publications
- Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Clinical case: idelalisib-induced immunoglobulin flare2017 | Central Library of Charles University, Third Faculty of Medicine
- Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression2007 | Third Faculty of Medicine
- Cellular immunity in the pathogenesis of type-1 diabetes mellitus2001 | Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hematologie v kostce +12023 | Central Library of Charles University, Third Faculty of Medicine
- Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab2023 | Third Faculty of Medicine
Loading network view...